Carmine Colavecchia
Senior Director & Real-World Evidence Scientist Argenx
Carmine is Senior Director of Real-World Evidence Sciences at Argenx, where Carmine leads global evidence generation within Medical Affairs to support the safe and effective use of therapies in rare disease. With over eight years at Pfizer, Carmine has extensive experience integrating real-world evidence across the product lifecycle, bridging clinical development, epidemiology, and access to inform decision-making. Carmine specializes in translating complex data into actionable insights that impact clinical practice, with a strong focus on rare disease, evidence strategy, and cross-functional collaboration.
Seminars
Thursday 29th October 2026
From Rare Data to Real Impact Translating Real World Evidence Into Clinical Decisions in Rare Disease
11:00 am
- Translating real world evidence into clinically meaningful insights in rare disease settings where data is limited and uncertainty is high
- Bridging real world evidence and medical affairs to ensure evidence is understood trusted and applied by clinicians and stakeholders globally
- Overcoming challenges of small populations fragmented datasets and lack of standardized endpoints to ensure evidence influences real world treatment decisions
